Failure of captopril to reverse the renal crisis of scleroderma
AUTOR(ES)
Brown, E. A.
RESUMO
Captopril, an oral inhibitor of angiotensin converting enzyme, has recently been described as causing a dramatic reversal of the renal crisis in scleroderma in 2 patients1. We report here 2 patients with scleroderma, hypertension, and rapidly deteriorating renal function who were given captopril. Despite good blood pressure control, captopril had no effect on renal function, both patients requiring long-term haemodialysis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1001059Documentos Relacionados
- Benign outcome of hypertensive renal crisis in scleroderma.
- Endothelial lesion and complement activation in patients with Scleroderma Renal Crisis
- Effect of captopril on renal function in patients with congestive heart failure.
- Failure of Relaxin in the Treatment of Scleroderma
- Comparison of captopril and ibopamine in mild to moderate heart failure.
